BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 26, 2012
View Archived Issues
New Wnt/catenin beta signaling inhibitor shows potential as cancer therapy
Read More
Durable submental fat reduction seen with ATX-101
Read More
Novel mTOR inhibitors reported
Read More
Merck KGaA develops novel inhibitors of tyrosine-protein kinases
Read More
GSK discloses new chemokine CCR4 receptor antagonists
Read More
U.S. university presents new vaccines for dengue
Read More
Peptide vaccine to enter phase IIa study
Read More
Hyperion Therapeutics acquires rights to Ravicti
Read More
Bioabsorbable stent shows promise in patients with coronary artery disease
Read More
Toray evaluates 11-beta-HSD1 inhibitor in obesity and diabetes models
Read More
New product extends therapeutic window of t-PA in stroke model
Read More
Coronado Biosciences signs agreement with Dr. Falk Pharma and OvaMed
Read More
GSK and Theravance complete registrational program
Read More
Byetta obtains European approval as add-on therapy to basal insulin
Read More
Medgenics receives clearance for phase IIa study in patients on dialysis
Read More
Mitsubishi Tanabe revises prescribing information for Imusera
Read More
NeuroDiscovery provides company update
Read More
Applications submitted for once-monthly risedronate sodium hydrate in Japan
Read More
Novel FLAP and leukotriene synthesis inhibitors patented
Read More
NeoPharm presents new protease-activated PAR2 receptor antagonists
Read More
Bionomics clear to initiate phase I/II trial of BNC-105
Read More
Kyorin Pharmaceutical reports novel AMPK activators
Read More
Pivotal LEAP trial reaches target enrollment
Read More
Endocyte receives approval for nonproprietary names of anticancer drug and companion imaging agent
Read More
EMA validates Raptor's MAA for RP-103
Read More
EMA to review Vivus' MAA for avanafil in ED
Read More